Work

ASO Author Reflections: Old Truths, New Data: Intraductal Oncocytic Papillary Neoplasm-Derived Pancreatic Cancer Requires Continued Surveillance

Year: 2025

Type: article

Abstract: PASTIntraductal papillary mucinous neoplasms (IPMNs) are recognized precursors to pancreatic cancer, with invasive subtypes historically categorized as tubular, colloid, or oncocytic.1 Among these, intraductal oncocytic papillary neoplasm (IOPN)-derived pancreatic cancer is recognized as a distinct entity with unique histologic and genetic features and has long been thought to carry a more favorable prognosis.However, due to its low incidence, comprehensive data on its clinical behavior and long-term outcomes remain limited.

Source: Annals of Surgical Oncology

DOI: 10.1245/s10434-025-18007-z

Authors: Camila Hidalgo Salinas, Joseph R. Habib, Ammar A. Javed, Greg D. Sacks

Institutions: University of Oxford, New York University, University Medical Center Utrecht, NYU Langone Health, St. Antonius Ziekenhuis

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,590